PARAGANGLIOMA
Clinical trials for PARAGANGLIOMA explained in plain language.
Never miss a new study
Get alerted when new PARAGANGLIOMA trials appear
Sign up with your email to follow new studies for PARAGANGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test re-engineered immune cells to fight advanced cancers
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy for people with advanced solid tumors, including melanoma, that have spread and are not responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack c…
Matched conditions: PARAGANGLIOMA
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated Apr 03, 2026 19:40 UTC
-
Targeted radiation therapy tested for rare, Hard-to-Treat tumors
Disease control Recruiting nowThis study is testing whether a radioactive drug called Lu-177-DOTATATE can safely help control rare adrenal and nerve-related tumors that cannot be removed by surgery. Adults with these specific tumors that show up on a special PET scan will receive four doses of the drug over s…
Matched conditions: PARAGANGLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Breakthrough radiation therapy targets Hard-to-Treat cancers with pinpoint precision
Disease control Recruiting nowThis study is testing a new targeted radiation treatment for adults with advanced neuroendocrine tumors that cannot be surgically removed or have spread. The treatment uses a radioactive substance that seeks out and delivers powerful radiation directly to cancer cells while tryin…
Matched conditions: PARAGANGLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Perspective Therapeutics • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New scan aims to spot returning brain tumors more clearly
Diagnosis Recruiting nowThis study is testing whether a new type of combined PET/MRI scan can help doctors better see if certain brain tumors have come back after treatment. It will involve 200 adults who have had surgery for specific brain tumors, like meningioma. The main goal is to see if this new sc…
Matched conditions: PARAGANGLIOMA
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Mar 30, 2026 14:29 UTC
-
New scans aim to pinpoint hidden tumors
Diagnosis Recruiting nowThis study is testing new types of imaging scans to better find and map rare nerve and adrenal tumors (neuroblastoma and pheochromocytoma/paraganglioma). Researchers will give participants special tracer injections and use PET or SPECT scans to see if these new methods can spot t…
Matched conditions: PARAGANGLIOMA
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Scientists hunt for hidden genetic causes of rare tumors
Knowledge-focused Recruiting nowThis study aims to discover new genetic causes of rare tumors called pheochromocytomas and paragangliomas. Researchers will analyze DNA from up to 2,000 patients and family members to find genes linked to these tumors. The goal is to improve genetic testing and help guide screeni…
Matched conditions: PARAGANGLIOMA
Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Scientists test new scan to see inside rare tumors
Knowledge-focused Recruiting nowThis study is testing a new type of PET scan to see if it can better show certain rare tumors called pheochromocytomas and paragangliomas. Up to 30 adults with these tumors will get the scan before their planned surgery or drug treatment. The goal is to learn more about the tumor…
Matched conditions: PARAGANGLIOMA
Phase: EARLY_PHASE1 • Sponsor: Heather Wachtel • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC
-
Hospital launches major effort to map the mysteries of rare diseases
Knowledge-focused Recruiting nowThis study aims to create a single, large registry to collect information on many different rare diseases. It will enroll about 380 patients already being treated at the Hospital Italiano de Buenos Aires who have one of the listed rare conditions. The goal is to gather data to be…
Matched conditions: PARAGANGLIOMA
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC